
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.
Kimberly-Clark (KMB) navigates a dynamic market with its "Powering Care" strategy amid currency volatility and softening demand. Dividend increases signal financial stability.
Kimberly-Clark navigates shifting consumer preferences while maintaining its dividend king status. A look at KMB's strategy, risks, and opportunities.
Kimberly-Clark (KMB) navigates economic headwinds and industry trends amid mixed analyst sentiment, balancing dividend stability with strategic transformation. Investors should remain cautious.
Kimberly-Clark faces a mixed outlook with strengths in dividends and brand recognition offset by challenges in growth and margins. The 'Powering Care' strategy aims to address these issues.
Kimberly-Clark (KMB) faces a mixed outlook amid strategic shifts and market volatility. Dividend appeal clashes with growth concerns. A detailed analysis follows.
Kimberly-Clark (KMB) balances stock gains with growth concerns. The 'Powering Care' strategy aims for innovation, but faces volatility. Dividend appeal requires financial health analysis.
An in-depth analysis of Kimberly-Clark's Q4 2024 performance, dividend increase, and strategic initiatives amid current market challenges.
A comprehensive analysis of [KMB] reveals key Q4 2024 results, dividend updates, and strategies shaping long-term market impact.
A detailed analysis of Kimberly-Clark’s transformation strategy, Q4 earnings, and dividend increase with actionable insights.